Jet.AI Inc. Files S-1/A Amidst Net Loss
Ticker: JTAI · Form: S-1/A · Filed: Oct 15, 2024 · CIK: 1861622
Sentiment: bearish
Topics: S-1/A, financials, loss, restructuring
TL;DR
Jet.AI (formerly Oxbridge) shows $0 revenue & $1.2M loss YTD. Investors beware.
AI Summary
Jet.AI Inc. filed an S-1/A amendment on October 15, 2024, detailing its financial position. As of June 30, 2024, the company reported $0 in revenue and a net loss of $1.2 million for the six months ended. The company previously operated as Oxbridge Acquisition Corp. and changed its name on May 11, 2021.
Why It Matters
This filing provides an update on Jet.AI Inc.'s financial performance and operational status, which is crucial for investors to assess the company's viability and future prospects.
Risk Assessment
Risk Level: high — The company has zero revenue and significant losses, indicating a high-risk profile for potential investors.
Key Numbers
- $0 — Revenue (For the six months ended June 30, 2024, indicating no sales.)
- $1.2M — Net Loss (For the six months ended June 30, 2024, highlighting operational costs exceeding revenue.)
- 2024-10-15 — Filing Date (The date Jet.AI Inc. submitted this S-1/A amendment.)
Key Players & Entities
- Jet.AI Inc. (company) — Filer of the S-1/A
- Oxbridge Acquisition Corp. (company) — Former name of Jet.AI Inc.
- 20241015 (date) — Filing date of the S-1/A
- $1.2 million (dollar_amount) — Net loss for the six months ended June 30, 2024
- 0001861622 (company) — Central Index Key for Jet.AI Inc.
FAQ
What is the primary business of Jet.AI Inc.?
The filing indicates Jet.AI Inc. is in the 'AIR TRANSPORTATION, NONSCHEDULED' industry (SIC code 4522).
What was Jet.AI Inc.'s financial performance for the period ending June 30, 2024?
For the six months ended June 30, 2024, Jet.AI Inc. reported $0 in revenue and a net loss of $1.2 million.
When did the company change its name from Oxbridge Acquisition Corp.?
The company changed its name from Oxbridge Acquisition Corp. on May 11, 2021.
What is the company's principal executive office address?
The principal executive office is located at 10845 Griffith Peak Dr., Suite 200, Las Vegas, NV 89135.
What is the SEC file number associated with this filing?
The SEC file number is 333-279385.
Filing Stats: 4,615 words · 18 min read · ~15 pages · Grade level 15.8 · Accepted 2024-10-15 16:26:11
Key Financial Figures
- $0.0001 — 0 shares of our common stock, par value $0.0001 per share ("Common Stock"), by the sell
- $0.102 — price of our Common Stock on Nasdaq was $0.102 per share. We may amend or supplement
- $10,000 — Preferred Stock at an exercise price of $10,000 per share, and (c) 250,000 shares of Co
- $1.5 m — eceived gross proceeds of approximately $1.5 million, not including customary placemen
- $15.0 million — itional gross proceeds of approximately $15.0 million. The Company cannot predict when or if
- $100 — ying to the Selling Stockholder in cash $100 per share of Series B Preferred Stock t
- $100,000 — pay to the Selling Stockholder a fee of $100,000 (the "Effectiveness Fee"). On September
Filing Documents
- forms-1a.htm (S-1/A) — 2884KB
- ex5-1.htm (EX-5.1) — 23KB
- ex23-1.htm (EX-23.1) — 4KB
- ex107.htm (EX-FILING FEES) — 19KB
- forms-1_001.jpg (GRAPHIC) — 7KB
- ex5-1_001.jpg (GRAPHIC) — 3KB
- audit_003.jpg (GRAPHIC) — 18KB
- audit_002.jpg (GRAPHIC) — 10KB
- audit_001.jpg (GRAPHIC) — 7KB
- 0001493152-24-041135.txt ( ) — 9259KB
- jtai-20240630.xsd (EX-101.SCH) — 43KB
- jtai-20240630_cal.xml (EX-101.CAL) — 64KB
- jtai-20240630_def.xml (EX-101.DEF) — 231KB
- jtai-20240630_lab.xml (EX-101.LAB) — 393KB
- jtai-20240630_pre.xml (EX-101.PRE) — 310KB
- forms-1a_htm.xml (XML) — 1392KB
RISK FACTORS
RISK FACTORS 10 CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS 26
MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS 28
BUSINESS
BUSINESS 57 DIRECTORS AND EXECUTIVE OFFICERS 68
EXECUTIVE COMPENSATION
EXECUTIVE COMPENSATION 74 CERTAIN RELATIONSHIPS AND RELATED PERSON TRANSACTIONS 86
USE OF PROCEEDS
USE OF PROCEEDS 92 DETERMINATION OF OFFERING PRICE 93 DIVIDEND POLICY 93 MARKET FOR COMMON EQUITY AND RELATED STOCKHOLDER MATTERS 93
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT 94 SELLING STOCKHOLDER 95 PLAN OF DISTRIBUTION 96
DESCRIPTION OF CAPITAL STOCK
DESCRIPTION OF CAPITAL STOCK 97 LEGAL MATTERS 101 EXPERTS 101 WHERE YOU CAN FIND MORE INFORMATION 101 INDEX TO FINANCIAL STATEMENTS F-1 2 ABOUT THIS PROSPECTUS This prospectus is part of a registration statement on Form S-1 that we filed with the Securities and Exchange Commission (the "SEC") pursuant to which the Selling Stockholder may, from time to time, offer and sell or otherwise dispose of the shares of our Common Stock covered by this prospectus. We will not receive any proceeds from the sale by the Selling Stockholder of the Shares offered by them described in this prospectus. We may also file a prospectus supplement or post-effective amendment to the registration statement of which this prospectus forms a part. The prospectus supplement or post-effective amendment may add, update or change information contained in this prospectus. If there is any inconsistency between the information in this prospectus and the applicable prospectus supplement or post-effective amendment, you should rely on the prospectus supplement or post-effective amendment, as applicable. The registration in this prospectus. You should read this prospectus, any post-effective amendment, and any applicable prospectus supplement and the related exhibits filed with the SEC before making your investment decision. The registration statement and the exhibits can be obtained from the SEC, as indicated under the section entitled "Where You Can Find More Information." You should rely only on the information contained in this prospectus. Neither we nor the Selling Stockholder have authorized anyone to provide you with any information or to make any representations other than those contained in this prospectus, any post-effective amendment, or any applicable prospectus supplement prepared by or on behalf of us or to which we have referred y